Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Iovance Biotherapeutics (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

BTOG 2018 | Lung cancer care: the technology is there, but what else is needed?

At the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland, we asked a number of experts what the key unanswered question in lung cancer is currently. The general consensus was that there were many questions, but each speaker had their own take. Here, Jeanette Dickson, MD, FRCR, of East and North Hertfordshire NHS Foundation Trust, Stevenage, UK, gives her answer, covering the hot topic of lung cancer screening, as well as treatment combination and sequencing.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.